167 related articles for article (PubMed ID: 21292344)
1. Regulation of T cell activation by TLR ligands.
Oberg HH; Juricke M; Kabelitz D; Wesch D
Eur J Cell Biol; 2011; 90(6-7):582-92. PubMed ID: 21292344
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of Toll-like receptors in T lymphocytes.
Kabelitz D
Curr Opin Immunol; 2007 Feb; 19(1):39-45. PubMed ID: 17129718
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells.
Liu G; Zhao Y
Immunology; 2007 Oct; 122(2):149-56. PubMed ID: 17848162
[TBL] [Abstract][Full Text] [Related]
4. TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell.
Chiffoleau E; Heslan JM; Heslan M; Louvet C; Condamine T; Cuturi MC
Int Immunol; 2007 Feb; 19(2):193-201. PubMed ID: 17208927
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptors and immune regulation: implications for cancer therapy.
Wang RF; Miyahara Y; Wang HY
Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
[TBL] [Abstract][Full Text] [Related]
6. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
[TBL] [Abstract][Full Text] [Related]
7. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
Conroy H; Marshall NA; Mills KH
Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
[TBL] [Abstract][Full Text] [Related]
8. Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands.
Oberg HH; Ly TT; Ussat S; Meyer T; Kabelitz D; Wesch D
J Immunol; 2010 May; 184(9):4733-40. PubMed ID: 20363971
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells and Toll-like receptors in tumor immunity.
Wang RF; Peng G; Wang HY
Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
[TBL] [Abstract][Full Text] [Related]
11. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
Qiao M; Thornton AM; Shevach EM
Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells and toll-like receptors in cancer therapy.
Wang RF
Cancer Res; 2006 May; 66(10):4987-90. PubMed ID: 16707417
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
14. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs.
Hackl D; Loschko J; Sparwasser T; Reindl W; Krug AB
Eur J Immunol; 2011 May; 41(5):1334-43. PubMed ID: 21469103
[TBL] [Abstract][Full Text] [Related]
15. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity.
Lauzon NM; Mian F; MacKenzie R; Ashkar AA
Cell Immunol; 2006 Jun; 241(2):102-12. PubMed ID: 17049504
[TBL] [Abstract][Full Text] [Related]
16. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms.
Demedts IK; Bracke KR; Maes T; Joos GF; Brusselle GG
Am J Respir Cell Mol Biol; 2006 Sep; 35(3):387-93. PubMed ID: 16627825
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection.
Lester RT; Yao XD; Ball TB; McKinnon LR; Kaul R; Wachihi C; Jaoko W; Plummer FA; Rosenthal KL
AIDS; 2008 Mar; 22(6):685-94. PubMed ID: 18356597
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis.
Mansson A; Adner M; Cardell LO
Respir Res; 2006 Feb; 7(1):36. PubMed ID: 16504163
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
[TBL] [Abstract][Full Text] [Related]
20. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
